AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF N-PHOSPHONACETYL-L-ASPARTATE (PALA), A NEW ANTIMETABOLITE

被引：0
作者：
ERLICHMAN, C
机构：
来源：
RECENT RESULTS IN CANCER RESEARCH | 1980年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：65 / 71
页数：7
相关论文
共 16 条
  • [1] CHADWICK M, 1978, P AM ASSOC CANC RES, V19, P182
  • [2] COLLINS KD, 1971, J BIOL CHEM, V246, P6599
  • [3] ERLICHMAN C, 1979, P AM ASSOC CANC RES, V20, P314
  • [4] ERVIN TJ, 1979, P AM ASSOC CANC RES, V20, P200
  • [5] GRALLA RJ, 1979, P AM ASSOC CANC RES, V20, P115
  • [6] JAYARAM HN, 1979, CANCER TREAT REP, V63, P1291
  • [7] JOHNSON RK, 1976, CANCER RES, V36, P2720
  • [8] REVERSAL OF TOXICITY AND ANTITUMOR ACTIVITY OF N-(PHOSPHONACETYL)-L-ASPARTATE BY URIDINE OR CARBAMYL-DL-ASPARTATE INVIVO
    JOHNSON, RK
    [J]. BIOCHEMICAL PHARMACOLOGY, 1977, 26 (01) : 81 - 84
  • [9] STABLE MUTANTS OF MAMMALIAN-CELLS THAT OVER-PRODUCE 1ST 3 ENZYMES OF PYRIMIDINE NUCLEOTIDE BIOSYNTHESIS
    KEMPE, TD
    SWYRYD, EA
    BRUIST, M
    STARK, GR
    [J]. CELL, 1976, 9 (04) : 541 - 550
  • [10] KENSLER TW, 1979, P AM ASSOC CANC RES, V20, P243
12